Literature DB >> 22420666

Comparison of the effects of marchantin C and fucoidan on sFlt-1 and angiogenesis in glioma microenvironment.

Yafeng Lv1, Qingxu Song, Qianqian Shao, Wenjuan Gao, Haiting Mao, Hongxiang Lou, Xun Qu, Xingang Li.   

Abstract

OBJECTIVES: This study aimed to examine the effects of marchantin C and fucoidan on angiogenesis induced by glioma cells and monocytes, and to elucidate the role of sFlt-1 in this process.
METHODS: T98G glioma cells and THP1 monocytes were pretreated with marchantin C or fucoidan, respectively. Conditioned media were used for endothelial cell tube formation assay and detection of sFlt-1 by ELISA. Depletion of sFlt-1 was achieved by a neutralizing antibody to assess its role in the process. KEY
FINDINGS: Marchantin C inhibited angiogenesis induced by T98G cells while fucoidan inhibited both T98G and THP1 cell-induced angiogenesis. In all three groups in which angiogenesis was inhibited, sFlt-1 level in the supernatants was elevated. Pretreatment of the conditioned media with sFlt-1 antibody restored the inhibited angiogenesis to a certain degree.
CONCLUSIONS: This study suggested for the first time that marchantin C and fucoidan could significantly inhibit angiogenesis induced by glioma cells or monocytes. Up-regulation of sFlt-1 played an important role in this process.
© 2012 The Authors. JPP © 2012 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22420666     DOI: 10.1111/j.2042-7158.2011.01430.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

Review 1.  Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.

Authors:  Farzaneh Atashrazm; Ray M Lowenthal; Gregory M Woods; Adele F Holloway; Joanne L Dickinson
Journal:  Mar Drugs       Date:  2015-04-14       Impact factor: 5.118

2.  Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer.

Authors:  Jia Sun; Jintang Sun; Bingfeng Song; Lin Zhang; Qianqian Shao; Yanguo Liu; Daoying Yuan; Yun Zhang; Xun Qu
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

3.  Evaluation of a Brown Seaweed Extract from Dictyosiphon foeniculaceus as a Potential Therapeutic Agent for the Treatment of Glioblastoma and Uveal Melanoma.

Authors:  Philipp Dörschmann; Christina Schmitt; Kaya Saskia Bittkau; Sandesh Neupane; Michael Synowitz; Johann Roider; Susanne Alban; Janka Held-Feindt; Alexa Klettner
Journal:  Mar Drugs       Date:  2020-12-08       Impact factor: 5.118

Review 4.  Small Molecules of Marine Origin as Potential Anti-Glioma Agents.

Authors:  Ana Alves; Paulo Costa; Madalena Pinto; Domingos Ferreira; Marta Correia-da-Silva
Journal:  Molecules       Date:  2021-05-05       Impact factor: 4.411

5.  Fucoidan inhibits the growth of hepatocellular carcinoma independent of angiogenesis.

Authors:  Cong Zhu; Rui Cao; Shuang-Xia Zhang; Ya-Nan Man; Xiong-Zhi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-12       Impact factor: 2.629

Review 6.  Anti-neoplastic Potential of Flavonoids and Polysaccharide Phytochemicals in Glioblastoma.

Authors:  Ayesha Atiq; Ishwar Parhar
Journal:  Molecules       Date:  2020-10-23       Impact factor: 4.411

Review 7.  Bibenzyls and bisbybenzyls of bryophytic origin as promising source of novel therapeutics: pharmacology, synthesis and structure-activity.

Authors:  Samapika Nandy; Abhijit Dey
Journal:  Daru       Date:  2020-08-15       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.